HIGHLIGHTS
- who: Satoshi Takai et al. from the University of Basel, Switzerland have published the paper: Humoral and cellular immune response and the safety of third SARS-CoV-2 mRNA vaccine with longer interval after the second vaccination in kidney transplant recipients, in the Journal: (JOURNAL)
- how: This study was conducted in accordance with the principles outlined in the Declaration of Helsinki. The results showed that the anti-SARS-CoV-2 antibody titer was much higher after the third vaccination in all KTRs with MMF and anti-SARS-CoV-2 antibody-positive after the second vaccination . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.